Top 35 Medical VC Funds & Investors in New Zealand (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Icehouse Ventures
VC Fund
|
8 | New Zealand, United States, Australia | Seed, Series A, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $485k–$20M |
|
New Zealand Growth Capital Partners
VC Fund
|
6 | New Zealand, United States, Australia | Seed, Venture - Series Unknown, Series A | Software, Information Technology, Health Care | $435k–$10M |
|
Uniservices
VC Fund
|
6 | New Zealand, United States, United Kingdom | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Medical Device, Biotechnology | $283k–$8.4M |
|
Pacific Channel
VC Fund
|
5 | New Zealand, Australia, United States | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Manufacturing, Biotechnology | $511k–$5.5M |
|
Powerhouse Ventures
VC Fund
|
4 | New Zealand, United States, Australia | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Software | $51k–$7.9M |
|
Enterprise Angels
VC Fund
|
4 | New Zealand, United States, United Kingdom | Seed, Venture - Series Unknown | Software, Information Technology, Health Care | $227k–$3.7M |
|
Matū Group
VC Fund
|
4 | New Zealand, Australia, United States | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Manufacturing | $337k–$25M |
|
IP Group
VC Fund
|
3 | United Kingdom, United States, Australia | Seed, Series A, Series B | Biotechnology, Health Care, Information Technology | $265k–$68M |
|
Global from Day One
VC Fund
|
3 | New Zealand, United States, China | Seed, Series A | Software, SaaS, Manufacturing | $694k–$18M |
|
Flying Kiwi Angels
VC Fund
|
2 | New Zealand, United States, United Kingdom | Seed, Angel, Venture - Series Unknown | Software, Information Technology, SaaS | $334k–$3.7M |
|
K1W1
VC Fund
|
2 | New Zealand, United States | Seed, Series A, Venture - Series Unknown | Software, Manufacturing, Artificial Intelligence | $550k–$18M |
|
Cure Kids Ventures
VC Fund
|
2 | New Zealand | Seed, Series A, Pre-Seed | Medical Device, Health Care, Manufacturing | $999k–$9.7M |
|
Blackbird Ventures
VC Fund
|
2 | Australia, United States, New Zealand | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $34k–$32M |
|
Founders Fund
VC Fund
|
2 | United States, United Kingdom, Germany | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $1.7M–$100M |
|
Movac
VC Fund
|
2 | New Zealand, United States, Australia | Seed, Venture - Series Unknown, Series A | Software, SaaS, Manufacturing | $1.4M–$16M |
|
Callaghan Innovation
VC Fund
|
2 | New Zealand, United States, Australia | Grant, Seed, Pre-Seed | Manufacturing, Software, Information Technology | $3.5k–$1M |
|
New Zealand Venture Investment Fund
VC Fund
|
2 | New Zealand, United States, Japan | Seed, Series A, Angel | Software, Biotechnology, SaaS | $400k–$8.8M |
|
Hillfarrance Venture Capital
VC Fund
|
1 | New Zealand, United Kingdom | Seed, Pre-Seed, Venture - Series Unknown | Software, Information Technology, Gaming | $362k–$2.3M |
|
American Gastroenterological Association
VC Fund
|
1 | United States, New Zealand | Series A, Series C | Medical, Health Care, Medical Device | $8M–$18M |
|
GD1 (Global From Day One)
VC Fund
|
1 | New Zealand, United States, China | Seed, Series A, Pre-Seed | Software, Manufacturing, Information Technology | $600k–$19M |
|
Sante Ventures
VC Fund
|
1 | United States, Canada, Japan | Series A, Series B, Series C | Health Care, Medical, Biotechnology | $1.8M–$80M |
|
KP Rx
VC Fund
|
1 | Australia, New Zealand | Seed, Venture - Series Unknown | Health Care, Medical Device, Medical | |
|
Novartis Venture Fund
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5.1M–$107M |
|
Victoria University of Wellington
VC Fund
|
1 | Australia, New Zealand | Pre-Seed, Seed | Health Care, Medical, Therapeutics | |
|
ArcAngels
VC Fund
|
1 | New Zealand | Seed, Series A, Venture - Series Unknown | Health Care, Biotechnology, Product Research | $518k–$1.3M |
|
Alt Ventures
VC Fund
|
1 | New Zealand, Australia | Seed, Pre-Seed, Angel | Software, Information Technology, SaaS | $419k–$6.6M |
|
IP Group Australia
VC Fund
|
1 | Australia, New Zealand | Seed, Series A, Pre-Seed | Biotechnology, Manufacturing, Renewable Energy | $811k–$30M |
|
Novaquest Capital Management
VC Fund
|
1 | United States, New Zealand, United Kingdom | Private Equity, Series A, Post-IPO Equity | Biotechnology, Health Care, Pharmaceutical | $3.6M–$200M |
|
Olympus Corporation of the Americas
VC Fund
|
1 | United States, New Zealand | Grant, Series A, Series C | Medical, Biotechnology, Health Care | |
|
Auckland UniServices
VC Fund
|
1 | New Zealand | Seed, Pre-Seed | Medical, Marketing, Nutrition | |
|
Hostplus
VC Fund
|
1 | Australia, United Kingdom, United States | Series A, Series B, Series C | Software, Biotechnology, Semiconductor | $6.3M–$111M |
|
Bioshore Ventures
VC Fund
|
1 | Australia, New Zealand | Seed, Venture - Series Unknown | Health Care, Medical, Medical Device | |
|
KiwiNet
VC Fund
|
1 | New Zealand | Pre-Seed | Medical, Health Care, Therapeutics | |
|
AngelHQ
VC Fund
|
1 | New Zealand, United States, Canada | Seed, Venture - Series Unknown, Angel | Software, SaaS, Manufacturing | $259k–$11M |
|
Olympus Innovation Ventures
VC Fund
|
1 | Spain, New Zealand, United States | Series A, Series B | Medical, Biotechnology, Biopharma | $18M–$20M |
| Access all 51 VC funds in New Zealand Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 279
- Round size: Seed $643k–$4.9M; Series A $2.5M–$20M; Venture - Series Unknown $485k–$19M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — raised $318k in 2023
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- Vessev — Electric hydrofoiling vessels built for commercial use. Quiet, efficient, and better for the world.
- First Table — Book the first table of the night and you'll get 50% off the food bill for two to four people!
The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 114
- Round size: Seed $532k–$4.3M; Series A $2M–$10M; Venture - Series Unknown $435k–$5.5M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $300M in 2020
Portfolio highlights
- Linca — Domestic refining of lithium, nickel & cobalt for the energy transition.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
Auckland University's commercialisation arm
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 36
- Round size: Seed $694k–$5M; Pre-Seed $283k–$1.3M; Venture - Series Unknown $1.6M–$8.4M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- RosterLab — RosterLab goal is to automate every part of the rostering process for healthcare.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
Investing in great people solving hard problems to create a better future.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: New Zealand, Australia, United States
Investor stats
- Total investments: 63
- Round size: Seed $517k–$5M; Pre-Seed $511k–$1.6M; Venture - Series Unknown $755k–$5.5M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Regen — We send daily recommendations to our farmers' phones based on their own farm data, so NZ can farm smarter.
- Androgenix —
- Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
powerHouse is a New Zealand intellectual property commercialisation company using private and public investment to develop new spin-out ventures sourced primarily from research partners such as universities and Crown Research Institutes. A pioneer of seed-stage investment in New Zealand, powerHouse focuses on the earliest stages of new high-value technology development. Unlike incubators that offer general business services to any innovative companies, powerHouse is extremely focused and selective. It rigorously screens each opportunity to identify those with the strongest intellectual property value and the greatest potential to gain an unfair advantage in global markets. powerHouse then invests in these companies, sourced from powerHouse's annual seed-stage fund and co-investment. powerHouse also runs an innovation education programme for studdents and organisations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 25
- Round size: Seed $285k–$7.9M; Pre-Seed $51k–$373k; Series A $255k–$7M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- VeriQuantix — VeriQuantix was spun out of the University of Queensland. VeriQuantix is an Australian startup specializing in cybersecurity, focusing on quantum technology to enhance the security of optical fiber communication networks. Their core innovation, Quantum Link Verification (QLV), is designed to detect and alert network operators to physical tappingattempts and intercept cyber attacks on fiber optic networks. This technology leverages quantum principles, specifically entangled photons, to verify the trustworthiness of network links by ensuring that any unauthorized access disrupts photon entanglement and triggers immediate alerts.
- Granular — Granular Energy provides solutions for managing and trading clean energy. We are the leading provider of energy certificate management software for utilities, helping to streamline certificate managment processes and enabling utilities to launch next-generation green offers, including transparency down to the hourly level.
- Liquid Instruments — Redefining the way scientists, engineers, students, and professionals experience test and measurement with Moku software-reconfigurable hardware platforms
Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Venture - Series Unknown
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 166
- Round size: Seed $328k–$3.7M; Venture - Series Unknown $227k–$3.6M
- Lead/follow: 11% lead, 89% follow
- Last fund: May invest from a new fund soon — raised $14M in 2019
Portfolio highlights
- Linca — Domestic refining of lithium, nickel & cobalt for the energy transition.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Scanabull — Scanabull is a 3D vision to measure cattle live weight quickly and accurately, reducing handling stress and giving farmers, agents, and processors clear, real‑time weight data. It makes weighing easy, analysis simple, and sharing seamless for everyone who relies on live weight or carcass weight decisions.
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed, Series A
- Geography: New Zealand, Australia, United States
Investor stats
- Total investments: 22
- Round size: Seed $473k–$4.6M; Pre-Seed $337k–$972k; Series A $2.3M–$25M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Advemto — Advemto is the manufacturer and developer of ultrafast spectroscopy systems that help researchers.
- Inhibit Coatings — Inhibit Coatings is a New Zealand based company developing novel antimicrobial and antifouling coatings.
- Captivate Technology — Captivate Technology company operates a clean-tech carbon capture platform. The platform enables cement manufacturers, geothermal power plants, and biogas producers to reduce pollution and contribute to environmental initiatives by using a metal-organic framework for CO2 adsorption as a solid-state material.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and create value out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 234
- Round size: Seed $265k–$7.6M; Series A $2.4M–$30M; Series B $7.9M–$68M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely actively investing — fresh fund, raised $50M in 2026
Portfolio highlights
- Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
- Matter Machine — Matter Machine is an AI-driven materials discovery company that creates technologies that use materials chemistry, machine learning, and automated experimentation to speed up the discovery and optimization of next-generation materials.
- Mach42 — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more...Investment focus
- Industry: Software, SaaS, Manufacturing
- Stage:Seed, Series A
- Geography: New Zealand, United States, China
Investor stats
- Total investments: 35
- Round size: Seed $694k–$5M; Series A $890k–$18M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $90M in 2021
Portfolio highlights
- eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
- Alimetry — Gastric Alimetry brings data-driven clarity to chronic gastric symptoms, helping clinicians diagnose with confidence.
- Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
Flying Kiwi Angels ? Helping Kiwi Startups
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Angel, Venture - Series Unknown
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 42
- Round size: Seed $334k–$3.7M; Angel $550k–$918k
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- PAM NZ — Forward a school newsletter, snap a screenshot, brain-dump your to-do list - PAM turns it all into a smart shared family calendar and helps manage the family tasks and events. Set up in 2 minutes. Free trial.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Kai's Education — Make coding education engaging for elementary and middle school students using robotics solutions that support STEM goals & modern classrooms. Shop Now!
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.
Show more...Investment focus
- Industry: Software, Manufacturing, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: New Zealand, United States
Investor stats
- Total investments: 135
- Round size: Seed $550k–$4.1M; Series A $1.8M–$18M; Venture - Series Unknown $2M–$10M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Hyades — Hyades is an AI-powered hyperspectral intelligence platform that offers soil and land insights.
- Vessev — Electric hydrofoiling vessels built for commercial use. Quiet, efficient, and better for the world.
- First Table — Book the first table of the night and you'll get 50% off the food bill for two to four people!
Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood Impact investing since 2008 Portfolio Companies Invested Health Tech Products Launched Product and Service Revenue Generated Jobs Created in NZ Paediatric Patients
Show more...Investment focus
- Industry: Medical Device, Health Care, Manufacturing
- Stage:Seed, Series A, Pre-Seed
- Geography: New Zealand
Investor stats
- Total investments: 15
- Round size: Seed $999k–$9.7M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- ISpy Nits — ISpyNits - everything you need to get rid of lice and nits once and for all
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 396
- Round size: Seed $34k–$7M; Pre-Seed $51k–$2.7M; Series A $3.8M–$32M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fresh fund, raised $812M in 2025
Portfolio highlights
- Vessev — Electric hydrofoiling vessels built for commercial use. Quiet, efficient, and better for the world.
- Heidi Health — Heidi Health develops an ambient AI medical scribe platform that automates clinical documentation and related tasks. It listens to patient-clinician conversations, transcribes key highlights, and then produces structured notes, referral letters, patient summaries, billing codes, and other downstream documents. The system supports customizable templates, allows editing during sessions, and integrates with various EHR systems while offering compliance with privacy and security standards. Clinicians in multiple specialties and care settings use Heidi to reduce administrative burden, improve focus on patient care, and streamline workflows.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Founders Fund is a San Francisco based venture capital firm investing in companies building revolutionary technologies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 1068
- Round size: Seed $1.7M–$14M; Series A $5.5M–$50M; Series B $15M–$100M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely actively investing — fresh fund, raised $6B in 2026
Portfolio highlights
- Quantcast — We are taking an entirely new approach to advertising on the open internet.
- Multiply Labs — Multiply Labs develops robotic systems that manufacture small-batch drugs. Current pharma production methods are manual, slow, and costly. We believe that the only way to scale them is with cloud-controlled robots.
- Ramp — Join thousands of forward-thinking businesses using Ramp to control spend, save time, and automate busywork.
Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.
Show more...Investment focus
- Industry: Software, SaaS, Manufacturing
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 74
- Round size: Seed $1.4M–$4.9M; Series A $1.5M–$16M; Venture - Series Unknown $2M–$13M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $125M in 2022
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- LawVu — Our all-in-one connected platform enables your legal team to manage all legal matters, contracts, spend and legal operations. Book your free demo now.
- Migco Pharmaceuticals — Migco Pharmaceuticals is a pharmaceutical company focused on designed to develop new drug therapies for migraine headache.
Callaghan Innovation supports businesses with research and development services, technical expertise, funding programs, and commercialization support. It provides scientific research, laboratory services, innovation programs, and industry partnerships across sectors including biotechnology, health technology, and advanced manufacturing. The agency is currently transferring its services to other public research organizations as part of New Zealand's science and innovation system reforms.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Grant, Seed, Pre-Seed
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 3457
- Round size: Seed $351k–$1M; Grant $3.5k–$139k; Pre-Seed $607k–$716k
- Lead/follow: 99% lead, 1% follow
Portfolio highlights
- Scanabull — Scanabull is a 3D vision to measure cattle live weight quickly and accurately, reducing handling stress and giving farmers, agents, and processors clear, real‑time weight data. It makes weighing easy, analysis simple, and sharing seamless for everyone who relies on live weight or carcass weight decisions.
- Sterling — Sterling operates an artificial intelligence platform designed to automate back-office operations for financial and accounting teams. The software deploys deterministic AI agents that execute repetitive tasks like accounts payable, accounts receivable, compliance checks, and bank reconciliations directly inside existing enterprise applications. Byfunctioning as a background virtual assistant, its value proposition centers on eliminating administrative bottlenecks while maintaining strict human-in-the-loop oversight and enterprise-grade audit standards.
- Forever Harvest — We are an Aotearoa New Zealand based cellular horticulture company, partnering with food & beverage manufacturers to develop new fruit & nut food solutions.
Your guide to finding and using government services.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Seed, Series A, Angel
- Geography: New Zealand, United States, Japan
Investor stats
- Total investments: 54
- Round size: Seed $515k–$1.8M; Angel $400k–$4.3M; Series A $1.6M–$8.8M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- MAPTO — Bringing industries together since 2008, Mapto.com stands as the premier platform for a global business directory. Serving millions of companies and suppliers worldwide.Mapto, the “Business Development Guide,” has been specially designed to offer an e-commerce solution that brings together all companies in the world and provides an excellent B2Cuser experience without sacrificing B2B functionality. The most significant difference from other marketplaces is that it is customer-supported!In today’s world, product, manufacturer, and communication demands are the basis of e-commerce searches on the internet. It restructures the “roadmap of e-commerce” by bringing all these demands together and making them accessible to users.
- Insite AI — The chosen partner by executives in RGM, insights, and I.T. to grow revenue and market share. Learn how CPGs win in pricing, assortment, trade and more.
- MarginFuel — MarginFuel provides intelligent price optimisation software that empowers rental vehicle operators to build profitable pricing strategies.
We exist to serve great entrepreneurs with honest advice and education, investment capital that is fair, and an open door to our international network and connections.
Show more...Investment focus
- Industry: Software, Information Technology, Gaming
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: New Zealand, United Kingdom
Investor stats
- Total investments: 33
- Round size: Seed $618k–$2.3M; Pre-Seed $362k–$1.2M; Venture - Series Unknown $900k–$2.1M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Kyoryu — Re-engineered dinosaurs roam a post-apocalyptic Japan. Follow the Samurai T-rex clan as they navigate complex dino clan rivalries.
- RiffRaff Games — Developers of Sleight of Hand
- Space Rock Games — Space Rock Games is the developer behind Criminals Within - a cooperative-only action game set in a medieval fantasy kingdom. Sign up to receive exclusive development updates!
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA, a 501(c6) organization, administers all membership and publicpolicy activities, while the AGA Institute, a 501(c3) organization, runs the organization’s practice, research and educational programs.On a monthly basis, the AGA Institute publishes two highly respected journals, Gastroenterology and Clinical Gastroenterology and Hepatology.The organization's annual meeting is Digestive Disease Week®, which is held each May and is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.The AGA Research Foundation provides digestive disease research grants on behalf of the AGA Institute.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A, Series C
- Geography: United States, New Zealand
Investor stats
- Total investments: 3
- Round size: Series A $8M–$18M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Alimetry — Gastric Alimetry brings data-driven clarity to chronic gastric symptoms, helping clinicians diagnose with confidence.
- Oshi Health — Oshi Health is a virtual-first gastroenterology (GI) clinic that diagnoses, treats and remotely monitors digestive (GI) conditions. Patients work with Oshi Health's integrated care team of gastroenterologists and GI-specialized nurse practitioners, registered dietitians, behavioral psychologists and health coaches to determine the root causesof their symptoms and use a personalized care plan that includes medication, dietary interventions and stress/anxiety reduction to get symptoms under control. This yields improved health outcomes, quality of life, satisfaction with care and workplace productivity while reducing overall healthcare cost.
- Virgo — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: New Zealand, United States, China
Investor stats
- Total investments: 71
- Round size: Seed $600k–$8.2M; Pre-Seed $860k–$11M; Series A $1.2M–$19M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely actively investing — fresh fund, raised $60M in 2026
Portfolio highlights
- Vessev — Electric hydrofoiling vessels built for commercial use. Quiet, efficient, and better for the world.
- Caruso — AI-native fund administration for private markets. Trusted by 950+ real estate, private credit, and PE funds to save time and grow AUM.
- Outlier Space — Outlier Space is an aerospace startup that builds a scalable, uncrewed, and reusable satellite platform designed to unlock access to microgravity. The company provides breakthrough infrastructure to safely return orbital payloads back to Earth. This technology allows sectors like pharmaceuticals, biotechnology, and advanced materials to manufactureand research products beyond Earth's atmospheric limits.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Privately Held Companies
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, Japan
Investor stats
- Total investments: 127
- Round size: Series A $1.8M–$37M; Series B $2.6M–$48M; Series C $5M–$80M
- Lead/follow: 61% lead, 39% follow
- Last fund: Likely actively investing — fresh fund, raised $330M in 2026
Portfolio highlights
- ReEmerge — ReEmerge is a medical technology company that develops Cognitive Network Restoration Therapy, a neurostimulation approach designed to address chronic cognitive impairment following brain injury. Its technology uses targeted electrical stimulation of neural networks to activate underperforming but viable brain circuits, with the goal of improving cognitive function and supporting recovery in patients with persistent impairments.
- RapidPulse — Explore RapidPulse for innovative stroke treatments and technologies. Book appointments or learn about our team and clinical trials.
- REVELOHEALTH — REVELOHEALTH provides advisory services. Their services include healthcare provider solutions, revenue cycle solutions, price transparency solutions, payment integrity, network claim repricing, data analytics, denial management, and direct-to-employer.
KP Rx is a 100% founder-owned investment firm focusing on private and early-stage public healthcare investments in Australia and New Zealand.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: Australia, New Zealand
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
- Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 237
- Round size: Series A $5.1M–$81M; Series B $11M–$107M; Series C $9M–$75M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $200M in 2009
Portfolio highlights
- Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
- Visiogen — Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions.The device isdesigned to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
- Rein Therapeutics — Rein Therapeutics is advancing a novel pipeline of first-in-class medicines to address unmet medical needs in orphan pulmonary and fibrosis indications.
A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.
Show more...Investment focus
- Industry: Health Care, Medical, Therapeutics
- Stage:Pre-Seed, Seed
- Geography: Australia, New Zealand
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Avalia Immunotherapies — Avalia is developing #immunotherapies and #vaccines for the treatment and prevention of infectious diseases and cancer.
At ArcAngels Funding, we connect female entrepreneurs across New Zealand to venture capital and investment to help their businesses grow.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Product Research
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: New Zealand
Investor stats
- Total investments: 9
- Round size: Seed $518k–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- chnnl — Optimise your employee wellbeing strategy with chnnl. Centralised resource management, track psychosocial risks and team psychological wellbeing measurement.
- VidApp — VidApp makes it easy to build, design and launch your own mobile and tv apps. Connect your current website or channel and build your audience today.
- Grater Goods — Grater Goods is a food and beverage manufacturing company that aims to provide customers with gourmet plant based deli items.
AmpliPHI Ventures provides wholesale investors access to the private market investment opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed, Angel
- Geography: New Zealand, Australia
Investor stats
- Total investments: 11
- Round size: Seed $1M–$6.6M; Pre-Seed $419k–$460k
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Arcanum AI — Rapidly build and integrate machine learning features with the Accelerate Platform library of pre-built workflows. Hosted API or deploy into your own cloud.
- Goodair Nosebuds — Goodair Nosebuds develops mechanical breathing technology to restore natural nasal functioning. It specializes in gently massaging upper airways using air, stimulating the body's natural defense system, and improving airway clarity, enabling users to enhance their well-being by balancing airway hydration.
- Sandfly Security — Sandfly agentless Linux EDR for critical infrastructure. Sandfly finds Linux threats without endpoint agents.
Ip Group Australia build and support outstanding intellectual property-based companies.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Renewable Energy
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, New Zealand
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$2.3M; Pre-Seed $811k–$896k; Series A $3M–$30M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- ElectraLith — The cleanest, most versatile and most cost-efficient method of extracting and refining lithium, the primary element of a sustainable future.
- MGA Thermal — MGA Thermal, specialists in thermal energy storage technology. Renewable, high-power, economical, modular, safe and sustainable thermal storage solutions.
- Atisama Therapeutics — Atisama Therapeutics is an Australian biotech company pioneering splice-switching oligonucleotide (SSO) therapies that restore normal gene transcription pathways to treat disease at the molecular level.
About NovaQuest Capital provides strategic capital to life science and healthcare companies. With experience managing over $2.75 billion of investor capital across multiple asset classes, the firm provides a robust life sciences and healthcare platform focused on promoting the development and gro...
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Private Equity, Series A, Post-IPO Equity
- Geography: United States, New Zealand, United Kingdom
Investor stats
- Total investments: 33
- Round size: Series A $3.6M–$179M; Private Equity $5.3M–$200M; Post-IPO Equity $50M–$125M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $90M in 2023
Portfolio highlights
- Mirna — Soon to be launched, our AI-powered MI:RNA platform is designed to detect a range of diseases prior to the development of clinical signs. This groundbreaking
- Kyntra Bio — FibroGen's research and development teams seek to identify and develop medicines for the treatment of chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis (IPF), Duchenne muscular dystrophy (DMD), and locally advanced pancreatic cancer (LAPC).
- Gallant — Gallant is developing a scalable stem cell therapy platform that will allow any veterinarian to routinely treat pets in a primary care setting, improving the lives of pets and their people. By systematically addressing challenges that previously hindered stem cell therapy adoption, the company aims to make stem cell products accessible in order toelevate the quality of life for all pets and the people that love them.
At Olympus, we put a lot of good back into the world, and what we do, really matters.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Grant, Series A, Series C
- Geography: United States, New Zealand
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely actively investing — fresh fund, raised $150M in 2025
Portfolio highlights
- Alimetry — Gastric Alimetry brings data-driven clarity to chronic gastric symptoms, helping clinicians diagnose with confidence.
- Swan EndoSurgical — Swan EndoSurgical provides endoluminal surgical robotic systems that will enhance patient care everywhere.
- On Target Laboratories — ON TARGET LABORATORIES discovers and develops fluorescent markers to target and illuminate cancer during surgery so it can be removed more completely.
UniServices grows and commercialises the research and expertise of the University of Auckland to create real-world impact.
Show more...Investment focus
- Industry: Medical, Marketing, Nutrition
- Stage:Seed, Pre-Seed
- Geography: New Zealand
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Opo Bio — Opo Bio develops cell lines for the cultivated meat industry and researchers.They are building a multi-species and multi-cell type product bank for research and commercial usage. They are creating infrastructure that will enable the industry to progress and more effectively scale.
- PhaseFoam — Cold chain solutions
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!
Show more...Investment focus
- Industry: Software, Biotechnology, Semiconductor
- Stage:Series A, Series B, Series C
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 64
- Round size: Series A $6.3M–$84M; Series B $20M–$111M; Series C $13M–$60M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Emesent — Solutions for GPS-denied environments - delivering revolutionary efficiency, safety and operational insights to underground mining and other industries.
- Universal Quantum — Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest supercomputers billions of years to solve.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Bioshore Ventures is an Australian MedTech-focused venture capital fund backing founders taking breakthrough medical technologies from R&D.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Venture - Series Unknown
- Geography: Australia, New Zealand
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Vexev — Vexev is on a mission to introduce innovative imaging diagnostic tools.
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Kiwi Innovation Network (KiwiNet) is a consortium of Universities and Crown Research Institutes & Entities who are dedicated to taking a collaborative approach to research commercialisation. The consortium consists of Plant and Food Research, Callaghan Innovation, AgResearch, Otago Innovation, Landcare Research, Lincoln University, Universityof Canterbury, Viclink, WaikatoLink, AUT Enterprises Ltd and Environmental Science & ResearchThrough KiwiNet, they seek to increase the scale and impact of scientific and technology based innovation with the aim of providing greater economic benefits to New Zealand.
Show more...Investment focus
- Industry: Medical, Health Care, Therapeutics
- Stage:Pre-Seed
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Avalia Immunotherapies — Avalia is developing #immunotherapies and #vaccines for the treatment and prevention of infectious diseases and cancer.
Learn about Angel HQ, Wellington's Angel Investing Network - the meeting place for ambitious startups and passionate investors.
Show more...Investment focus
- Industry: Software, SaaS, Manufacturing
- Stage:Seed, Venture - Series Unknown, Angel
- Geography: New Zealand, United States, Canada
Investor stats
- Total investments: 58
- Round size: Seed $351k–$2.5M; Angel $367k–$1M; Venture - Series Unknown $259k–$11M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Luminoma — Luminoma will enable easy access to objective and precise skin cancer screening. With Luminoma, clinicians can confidently discern malignant from benign, reducing unnecessary referrals and biopsies.
- Upstock — Easily manage all your hospitality, foodservice and FMCG grocery orders. Automate invoicing, pricing, payments and logistics with powerful AI tools.
- Factor — Plug and play forecasting and pricing tools for modern energy utilities.
Olympus Innovation Ventures is an investment firm.
Show more...Investment focus
- Industry: Medical, Biotechnology, Biopharma
- Stage:Series A, Series B
- Geography: Spain, New Zealand, United States
Investor stats
- Total investments: 3
- Round size: Series A $18M–$20M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Alimetry — Gastric Alimetry brings data-driven clarity to chronic gastric symptoms, helping clinicians diagnose with confidence.
- MaxQ Medical — MaxQ Medical is a manufacturing company.
- Universal Diagnostics — Universal Diagnostics S.L. (UDX) is a Spanish in-vitro diagnostics company developing a platform of minimally-invasive, blood-based solutions for detecting cancer early when treatment options are more plentiful and survival rates are still high. UDX believes that the best way to fight against cancer is by detecting it early.The UDX diagnosticplatform is designed to detect various cancer types, e.g. colorectal, liver, pancreatic, lung, and gastric cancer via one simple blood test. The assays rely on a curated set of proprietary methylation marker panels; a simple blood sample collected as part of a routine check-up, can be processed at a reference laboratory or hospital using standard equipment and then uploaded to the UDX Cloud for final algorithmic analysis.UDX’s first marker panel is a colorectal cancer screening test. The test identifies individuals who need to be referred for colonoscopy. Colorectal cancer is the 3rd most frequent cancer and 2nd deadliest cancer worldwide. The challenge is that colorectal cancer is mostly detected in late stages, with significantly decreased survival rates (11% survival rate in stage IV vs. 85% survival rate in stage I).To develop the test and execute its R&D and operations, UDX partners with international research institutions, hospitals, universities, and biobanks around the globe.
Medical VC funding in New Zealand at a glance
Stats across 161 deals from 51 investors.
Access all 51 VC funds in New Zealand Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in New Zealand investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 51 VC funds investing in New Zealand Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!